Your browser is no longer supported. Please, upgrade your browser.
Enzo Biochem, Inc.
Index- P/E- EPS (ttm)-0.22 Insider Own8.10% Shs Outstand48.01M Perf Week-1.68%
Market Cap134.23M Forward P/E- EPS next Y- Insider Trans-10.67% Shs Float44.13M Perf Month-15.61%
Income-10.60M PEG- EPS next Q- Inst Own60.70% Short Float3.39% Perf Quarter-15.12%
Sales96.60M P/S1.39 EPS this Y- Inst Trans-1.65% Short Ratio1.18 Perf Half Y40.38%
Book/sh1.29 P/B2.26 EPS next Y- ROA-9.30% Target Price- Perf Year3.55%
Cash/sh0.97 P/C3.02 EPS next 5Y- ROE-17.50% 52W Range1.80 - 4.85 Perf YTD15.87%
Dividend- P/FCF- EPS past 5Y-64.00% ROI-43.20% 52W High-39.38% Beta0.90
Dividend %- Quick Ratio2.00 Sales past 5Y-4.90% Gross Margin41.40% 52W Low63.33% ATR0.15
Employees408 Current Ratio2.30 Sales Q/Q62.40% Oper. Margin-12.30% RSI (14)39.77 Volatility5.85% 4.75%
OptionableYes Debt/Eq0.19 EPS Q/Q129.60% Profit Margin-11.00% Rel Volume0.11 Prev Close2.92
ShortableYes LT Debt/Eq0.07 EarningsMar 15 AMC Payout- Avg Volume1.27M Price2.94
Recom- SMA20-7.12% SMA50-9.39% SMA20011.43% Volume23,402 Change0.68%
Oct-18-11Reiterated Rodman & Renshaw Mkt Outperform $7 → $5
Sep-23-09Initiated Rodman & Renshaw Mkt Outperform $14
Sep-13-07Initiated Lazard Capital Buy $19
May-05-21 12:05PM  
Apr-21-21 08:00AM  
Mar-31-21 03:41AM  
Mar-17-21 04:15PM  
Mar-16-21 09:59AM  
Mar-15-21 04:05PM  
Mar-12-21 08:00AM  
Mar-04-21 08:00AM  
Mar-02-21 08:00AM  
Mar-01-21 04:05PM  
Feb-03-21 08:30AM  
Jan-30-21 03:37AM  
Jan-22-21 07:26PM  
Jan-20-21 08:14AM  
Jan-15-21 11:39AM  
Jan-05-21 01:27PM  
Jan-04-21 07:00AM  
Dec-31-20 07:30PM  
Dec-28-20 08:00AM  
Dec-24-20 02:06PM  
Dec-15-20 08:00AM  
Dec-10-20 07:53PM  
Dec-09-20 04:01PM  
Dec-02-20 08:00AM  
Dec-01-20 01:22AM  
Nov-25-20 08:00AM  
Nov-18-20 01:00PM  
Nov-17-20 08:00AM  
Nov-05-20 08:00AM  
Oct-27-20 08:00AM  
Oct-14-20 07:53AM  
Oct-13-20 04:01PM  
Oct-06-20 03:42PM  
Sep-15-20 09:29AM  
Sep-08-20 08:00AM  
Aug-03-20 03:15PM  
Jul-21-20 08:30AM  
Jul-17-20 01:56PM  
Jul-13-20 08:50AM  
Jun-30-20 01:15PM  
Jun-25-20 05:50PM  
Jun-23-20 08:30AM  
Jun-08-20 04:05PM  
Jun-03-20 04:05PM  
May-20-20 08:00AM  
May-12-20 08:00AM  
Apr-29-20 08:00AM  
Apr-23-20 08:00AM  
Mar-24-20 07:50AM  
Mar-20-20 06:00AM  
Mar-13-20 07:38PM  
Mar-09-20 02:44PM  
Mar-06-20 08:00AM  
Mar-05-20 04:05PM  
Mar-03-20 10:00AM  
Feb-25-20 10:27AM  
Feb-19-20 05:16PM  
Feb-12-20 09:18AM  
Feb-11-20 08:30AM  
Feb-07-20 08:00AM  
Feb-06-20 03:07PM  
Jan-30-20 08:13AM  
Jan-29-20 10:51AM  
Jan-28-20 05:45PM  
Jan-27-20 06:45AM  
Jan-21-20 02:36PM  
Jan-17-20 03:02PM  
Jan-16-20 01:03PM  
Jan-13-20 08:00AM  
Jan-08-20 09:00AM  
Dec-31-19 10:48AM  
Dec-30-19 09:00AM  
Dec-14-19 07:01PM  
Dec-10-19 04:15PM  
Dec-05-19 04:15PM  
Nov-09-19 09:18AM  
Oct-17-19 08:44PM  
Oct-15-19 04:15PM  
Oct-11-19 09:00AM  
Oct-10-19 08:06AM  
Sep-24-19 09:00AM  
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Products, Clinical Services, and Therapeutics. The Products segment develops, manufactures, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment provides its products to scientific experts in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Clinical Services segment provides routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, or search for an otherwise undiagnosed condition. It operates a full-service clinical laboratory in Farmingdale, New York; a network of 34 patient service centers in New York and New Jersey; and a free-standing A'STAT' or rapid response laboratories in New York City and Connecticut, as well as a full-service phlebotomy center and an in-house logistics department. The Therapeutics segment develops novel approaches in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. The company markets its products and services through its direct sales force and a network of distributors in the United States and internationally. Enzo Biochem, Inc. was founded in 1976 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HARBERT MANAGEMENT CORP10% OwnerMar 16Sale4.65300,0001,393,9005,175,913Mar 17 05:28 PM
HARBERT MANAGEMENT CORP10% OwnerMar 15Sale4.83144,768698,8405,475,913Mar 17 05:28 PM